BioLineRx Announces Positive Preclinical Results for Novel Treatment for ... PR Newswire (press release) Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, assessed the effect of BL-8040 alone, and in combination with imatinib, on the proliferation of human CML cells in culture and on ... |
